Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
Cleveland Clinic Journal of Medicine|November 30, 2011
PML and rheumatology: the contribution of disease and drugsEamonn S MolloyRheumatology (Oxford, England)|February 20, 2016
The role of toll like receptors in giant cell arteritisLorraine O'Neill, Eamonn S MolloySeminars in Arthritis and Rheumatism|May 20, 2018
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trialRichard Conway, Lorraine O'Neill, Phil Gallagher, et al.Current Opinion in Rheumatology|February 8, 2006
Basic calcium phosphate crystals: pathways to joint degenerationEamonn S Molloy, Geraldine M McCarthyNature Reviews. Rheumatology|August 4, 2009
Therapy: Targeted but not trouble-free: efalizumab and PMLEamonn S Molloy, Leonard H CalabreseCurrent Rheumatology Reports|May 12, 2004
How crystals damage tissueEamonn S Molloy, Geraldine M McCarthyRheumatic Diseases Clinics of North America|March 1, 2006
Advances in the treatment of small vessel vasculitisEamonn S Molloy, Carol A LangfordAutoimmunity Reviews|August 14, 2008
Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?Eamonn S Molloy, Leonard H CalabreseArthritis and Rheumatism|March 17, 2012
Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapiesEamonn S Molloy, Leonard H CalabreseArthritis and Rheumatism|December 2, 2009
Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseasesEamonn S Molloy, Leonard H CalabresePageof 18